Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works by Pajiep, Marie
Results: 5
1
2
Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories—A French population‐based study using the French national health data system.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E307, doi. 10.1002/ajh.26621
- By:
- Publication type:
- Article
3
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 4, p. 1338, doi. 10.1111/bcp.15576
- By:
- Publication type:
- Article
4
Drug–drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: A study using the French health insurance database.
- Published in:
- Fundamental & Clinical Pharmacology, 2023, v. 37, n. 5, p. 994, doi. 10.1111/fcp.12899
- By:
- Publication type:
- Article
5
Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.675609
- By:
- Publication type:
- Article